Journal of Hepatology
Volume 49, Issue 3 , Pages 316-322, September 2008

Cerebral immune activation in chronic hepatitis C infection: A magnetic resonance spectroscopy study

  • Daniel M. Forton

      Affiliations

    • Hepatology Section, Division of Medicine, Imperial College London, St. Mary’s Hospital, London, United Kingdom
    • Robert Steiner Magnetic Resonance Unit, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Hospital, London, United Kingdom
    • Corresponding Author InformationCorresponding author. Present address: Department of Gastroenterology and Hepatology, St. George’s Hospital, University of London, Blackshaw Road, London SW17 0QT, United Kingdom. Tel.: +44 208 725 3032; fax: +44 208 725 3520.
  • ,
  • Gavin Hamilton

      Affiliations

    • Department of Radiology, University of California San Diego, San Diego, USA
  • ,
  • Joanna M. Allsop

      Affiliations

    • Robert Steiner Magnetic Resonance Unit, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Hospital, London, United Kingdom
  • ,
  • Vijay P. Grover

      Affiliations

    • Hepatology Section, Division of Medicine, Imperial College London, St. Mary’s Hospital, London, United Kingdom
    • Robert Steiner Magnetic Resonance Unit, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Hospital, London, United Kingdom
  • ,
  • Keith Wesnes

      Affiliations

    • Cognitive Drug Research Limited, Goring-on-Thames, United Kingdom
  • ,
  • Catherine O’Sullivan

      Affiliations

    • Robert Steiner Magnetic Resonance Unit, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Hospital, London, United Kingdom
  • ,
  • Howard C. Thomas

      Affiliations

    • Hepatology Section, Division of Medicine, Imperial College London, St. Mary’s Hospital, London, United Kingdom
  • ,
  • Simon D. Taylor-Robinson

      Affiliations

    • Hepatology Section, Division of Medicine, Imperial College London, St. Mary’s Hospital, London, United Kingdom
    • Robert Steiner Magnetic Resonance Unit, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Hospital, London, United Kingdom

Received 10 February 2008; accepted 6 March 2008. published online 25 April 2008.

Associate Editor: R.P. Perrillo

Background/Aims

Abnormal cerebral metabolism and cognitive impairments have been reported in patients with chronic hepatitis C (HCV) but studies have failed to demonstrate a relationship between these findings.

Methods

Twenty-five HCV-positive patients with histologically-mild liver disease were studied with cerebral proton magnetic resonance spectroscopy (MRS), using acquisition parameters to quantify myo-inositol (mI) and other metabolites in frontal white matter (FWM). Patients underwent automated attention and working memory tests (Cognitive Drug Research test system).

Results

The mean mI/ creatine ratio in the HCV+ve patients (0.64, SD 0.21) was significantly higher (p=0.02) than in healthy controls (0.52, SD 0.10). On cognitive testing, the HCV+ve patients showed impairments in 2/4 composite scores, reflecting working memory and attention, compared to normative data from healthy volunteers (p<0.005) and HCV−ve controls (p=0.03). There was a significant association between elevated FWM mI/creatine and prolonged working memory reaction times (R=0.72, p=0.002).

Conclusions

Elevated FWM mI/ creatine is a feature of HIV-related minor cognitive-motor disorder. It is associated with infection and immune activation of microglial cells. The similar findings in this study suggest that cerebral immune activation may also occur in HCV infection. This may underlie the mild neurocognitive impairment and neuropsychological symptoms observed in a proportion of patients.

Abbreviations: HCV, hepatitis C virus, MRS, magnetic resonance spectroscopy, mI, myo-inositol, FWM, frontal white matter, SD, standard deviation, HIV, human immunodeficiency virus, HRQL, health related quality of life, CNS, central nervous system, Cho, Choline, Cr, Creatine, NAA, N-acetyl aspartate, MCMD, minor cognitive motor disorder, HAD, HIV-associated dementia, IVDU, intravenous drug use, MDU, major recreational drug use, CDR, cognitive drug research, MDMA, 3,4-methylenedioxymethamphetamine, TNF, tumour necrosis factor, LPS, lipopolysaccharide, BBB, blood brain barrier, HPA, hypothalamic pituitary axis, IL, interleukin

Keywords: Hepatitis C, Cognitive, Magnetic, Spectroscopy, myo-inositol

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 The authors declare that they do not have anything to disclose regarding funding from industries or conflict of interest with respect to this manuscript.

PII: S0168-8278(08)00228-6

doi:10.1016/j.jhep.2008.03.022

Journal of Hepatology
Volume 49, Issue 3 , Pages 316-322, September 2008